Literature DB >> 15385815

Mesenchymal stem cell content of human vertebral bone marrow.

Norbert Ahrens1, Ariane Tormin, Margit Paulus, Daniela Roosterman, Abdulgabar Salama, Veit Krenn, Ulf Neumann, Stefan Scheding.   

Abstract

Mesenchymal stem cells (MSCs) are capable of down-regulating alloimmune responses and promoting the engraftment of hematopoietic stem cells. MSCs may therefore be suitable for improving donor-specific tolerance induction in solid-organ transplantation. Cells from cadaveric vertebral bone marrow (V-BM), aspirated iliac crest-BM, and peripheral blood progenitor cells were compared. Cells were characterized by flow cytometry and colony assays. MSCs generated from V-BM were assayed for differentiation capacity and immunomodulatory function. A median 5.7 x 10(8) nucleated cells (NCs) were recovered per vertebral body. The mesenchymal progenitor, colony-forming unit-fibroblast, frequency in V-BM (11.6/10(5) NC, range: 6.0-20.0) was considerably higher than in iliac crest-BM (1.4/10(5) NC, range: 0.4-2.6) and peripheral blood progenitor cells (not detectable). MSC generated from V-BM had the typical MSC phenotype (CD105(pos)CD73(pos)CD45(neg)CD34(neg)), displayed multilineage differentiation potential, and suppressed alloreactivity in mixed lymphocyte reactions. V-BM may be an excellent source for MSC cotransplantation approaches.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385815     DOI: 10.1097/01.tp.0000133305.81823.2a

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

Review 1.  [Stem cell therapy and tissue engineering in regenerative urology].

Authors:  M Vaegler; B Amend; W Aicher; A Stenzl; K-D Sievert
Journal:  Urologe A       Date:  2013-12       Impact factor: 0.639

2.  CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization.

Authors:  Ariane Tormin; Ou Li; Jan Claas Brune; Stuart Walsh; Birgit Schütz; Mats Ehinger; Nicholas Ditzel; Moustapha Kassem; Stefan Scheding
Journal:  Blood       Date:  2011-03-17       Impact factor: 22.113

3.  Proliferation and osteoblastic differentiation of bone marrow stem cells: comparison of vertebral body and iliac crest.

Authors:  Woo-Kie Min; Jae-Sung Bae; Byung-Chul Park; In-Ho Jeon; Hee Kyung Jin; Min-Jung Son; Eui Kyun Park; Shin-Yoon Kim
Journal:  Eur Spine J       Date:  2010-05-13       Impact factor: 3.134

4.  Development and validation of a procedure to isolate viable bone marrow cells from the vertebrae of cadaveric organ donors for composite organ grafting.

Authors:  Vijay S Gorantla; Stefan Schneeberger; Linda R Moore; Vera S Donnenberg; Ludovic Zimmerlin; W P Andrew Lee; Albert D Donnenberg
Journal:  Cytotherapy       Date:  2011-09-12       Impact factor: 5.414

5.  Overcoming the barriers to umbilical cord blood transplantation.

Authors:  Susan Staba Kelly; Simrit Parmar; Marcos De Lima; Simon Robinson; Elizabeth Shpall
Journal:  Cytotherapy       Date:  2010-04       Impact factor: 5.414

Review 6.  Ex vivo expansion of cord blood.

Authors:  S S Kelly; C B S Sola; M de Lima; E Shpall
Journal:  Bone Marrow Transplant       Date:  2009-10-05       Impact factor: 5.483

7.  Efficacy of autologous stem cell-based therapy for osteonecrosis of the femoral head in sickle cell disease: a five-year follow-up study.

Authors:  Gildasio Cerqueira Daltro; Vitor Fortuna; Eliane Silva de Souza; Marcela Miranda Salles; Ana Claudia Carreira; Roberto Meyer; Songeli Menezes Freire; Radovan Borojevic
Journal:  Stem Cell Res Ther       Date:  2015-05-29       Impact factor: 6.832

8.  Term amniotic fluid: an unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applications.

Authors:  Roksana Moraghebi; Agnete Kirkeby; Patricia Chaves; Roger E Rönn; Ewa Sitnicka; Malin Parmar; Marcus Larsson; Andreas Herbst; Niels-Bjarne Woods
Journal:  Stem Cell Res Ther       Date:  2017-08-25       Impact factor: 6.832

9.  Vertebral body versus iliac crest bone marrow as a source of multipotential stromal cells: Comparison of processing techniques, tri-lineage differentiation and application on a scaffold for spine fusion.

Authors:  Evangelos M Fragkakis; Jehan Jomaa El-Jawhari; Robert A Dunsmuir; Peter A Millner; Abhay S Rao; Karen T Henshaw; Ippokratis Pountos; Elena Jones; Peter V Giannoudis
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

10.  Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies.

Authors:  Ou Li; Ariane Tormin; Berit Sundberg; Johan Hyllner; Katarina Le Blanc; Stefan Scheding
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.